Chao W.

Chao W. currently serves as Associate Director of Clinical Science in Radiopharmaceuticals at Lantheus since October 2024. Prior experience includes roles at The Whiteoak Group, Inc. as Director of Clinical Development and Associate Director of Clinical Development for Solid Tumors, along with positions as Senior Clinical Scientist and Clinical Scientist. Chao has also completed a Clinical Fellowship in BMT at Children's National Hospital and worked as an Associate Researcher at Nebraska Medicine. Chao W. holds a PharmD in Solid Tumors and Transplant from the University of Nebraska Medical Center, a postgraduate degree from Harvard Medical School, a Certificate in Literature Evaluation from the University of Minnesota, and a Bachelor of Pharmacy from Shenyang Pharmaceutical University.